NMIMC
CYTK icon

Northwestern Mutual Investment Management Company’s Cytokinetics CYTK Stock Holding History

Northwestern Mutual Investment Management Company’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.6M Buy
30,541
+3,150
+12% +$226K 0.03% 240
2026
Q1 		$1.81M Buy
27,391
+36
+0.1% +$2.29K 0.03% 341
2025
Q4 		$1.74M Buy
27,355
+684
+3% +$42.5K 0.02% 353
2025
Q3 		$1.47M Buy
26,671
+5
+0% +$206 0.02% 412
2025
Q2 		$881K Buy
26,666
+427
+2% +$14.9K 0.01% 598
2025
Q1 		$1.05M Buy
26,239
+11
+0% +$506 0.02% 518
2024
Q4 		$1.23M Buy
26,228
+124
+0.5% +$6.44K 0.03% 468
2024
Q3 		$1.38M Buy
26,104
+513
+2% +$28.6K 0.03% 414
2024
Q2 		$1.39M Buy
25,591
+3,721
+17% +$225K 0.04% 379
2024
Q1 		$1.53M Buy
+21,870
New +$1.69M 0.04% 346

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northwestern Mutual Investment Management Company's CYTK Position: Q2 2026 in Review

Northwestern Mutual Investment Management Company increased its Cytokinetics (CYTK) stake by 12% in Q2 2026, buying an estimated $226K and bringing the position to 30,541 shares worth $2.6M. The position accounts for 0.03% of the portfolio, ranked #240.

Northwestern Mutual Investment Management Company first reported a position in CYTK in Q1 2024 and has held it in 10 quarters since. 269 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Northwestern Mutual Investment Management Company held 30,541 shares of Cytokinetics worth $2.6M as of Q2 2026.
  • Northwestern Mutual Investment Management Company bought 3,150 Cytokinetics shares in Q2 2026, an estimated $226K.
  • Cytokinetics made up 0.03% of Northwestern Mutual Investment Management Company's portfolio in Q2 2026, its #240 holding.
  • Northwestern Mutual Investment Management Company first reported a position in Cytokinetics in Q1 2024 and has held it in 10 quarters since.
  • 269 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Northwestern Mutual Investment Management Company's 13F filing for Q2 2026, filed 12 Aug 2026.